Case-based learning: chronic breathlessness in adults The causes and management of breathlessness in adults, with a focus on chronic breathlessness.…
Pulmonary hypertension: recognition, diagnosis and management An overview of the pathogenesis, recognition, diagnosis and treatment of pulmonary hypertension.…
Case-based learning: gastro-oesophageal reflux disease in adults How to recognise the signs and symptoms of this increasingly common gastric condition, using case studies to provide advice on medicines management.…
MHRA reviewing safety of asthma drug as Yellow Card reports increase The Medicines and Healthcare products Regulatory Agency is reviewing montelukast after there were 143 reports of psychiatric disorders associated with the drug in 2023.…
Respiratory syncytial virus in children A common cause of respiratory tract infection in children, respiratory syncytial virus has similar features to other viral illnesses. Pharmacists therefore need to know how to recognise differential diagnoses and when it is appropriate to refer.…
Poorly controlled asthma eight times worse for greenhouse gases, study finds Researchers found poorly controlled asthma contributed the same amount of excess greenhouse gases as that of 124,000 homes in the UK each year.…
Patient safety alert warns of salbutamol nebuliser liquid shortages with no date for resupply An alert says that while alternative nebuliser liquids are available, manufacturers cannot support the increase in demand.…
How a pharmacist-led primary care clinic can improve respiratory care Nazir Hussain, a specialist respiratory pharmacist at Dudley Integrated Health and Care NHS Trust, shares how he is improving respiratory care by offering GP-based clinics to help patients manage their COPD and asthma.…
Test yourself: the 2023 CPD and Learning quiz Assess your knowledge on topics ranging from infectious diseases, to professional skills, to cardiology, in our end-of-year CPD and learning quiz.…
European regulator’s committee recommends new safety measures for medicines containing pseudoephedrine The European Medicines Agency's risk assessment committee has recommended that medicines containing pseudoephedrine should not be used in patients with severe or uncontrolled high blood pressure, or people with severe acute or chronic kidney disease or failure.…
